norfloxacin has been researched along with imipenem, anhydrous in 49 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 15 (30.61) | 18.7374 |
1990's | 7 (14.29) | 18.2507 |
2000's | 17 (34.69) | 29.6817 |
2010's | 8 (16.33) | 24.3611 |
2020's | 2 (4.08) | 2.80 |
Authors | Studies |
---|---|
Dumas, JL; Köhler, T; Reinhardt, A; Ricou, B; Rohner, P; van Delden, C; Wood, P | 1 |
Caniça, M; Ferreira, E; Leitão, J; Manageiro, V; Mendonça, N | 1 |
Beceiro, A; Bou, G; Canle, D; Fernández, A; Lasa, I; Latasa, C; Mallo, S; Molina, F; Pérez, A; Pérez, S; Poza, M; Tomás, Mdel M; Villanueva, R | 1 |
Brazas, MD; Breidenstein, EB; Hancock, RE; Overhage, J | 1 |
Arakawa, Y; Suzuki, S; Wachino, J; Yamane, K | 1 |
Badur, S; Cagatay, AA; Carrër, A; Eraksoy, H; Nordmann, P; Poirel, L | 1 |
Cattoir, V; Nordmann, P; Poirel, L | 1 |
Berçot, B; Nordmann, P; Poirel, L | 1 |
Baptista, BC; Correia, JD; da Fonseca, JD; Martínez-Martínez, L; Pomba, C | 1 |
Chevalier, J; Davin-Regli, A; Dupont, M; Lavigne, JP; Pagès, JM; Sotto, A; Tran, QT | 1 |
Bartolomé, R; Coelho, A; González-López, JJ; Larrosa, MN; Lavilla, S; Prats, G | 1 |
Espinal, P; Gibert, I; Marti, S; Martínez, P; Roca, I; Vila, J | 1 |
Gebreyes, WA; Rajamohan, G; Srinivasan, VB | 1 |
Courvalin, P; Coyne, S; Guigon, G; Périchon, B | 1 |
Hakanen, AJ; Huovinen, P; Kotilainen, P; Lehtopolku, M; Nakari, UM; Siitonen, A | 1 |
Anderson, KC; Kellogg, GE; Sarkar, A | 1 |
Gao, F; Huang, G; Xiao, J | 1 |
Aubert, G; Dorche, G; Pozzetto, B | 1 |
Fukuda, H; Hashimoto, H; Hirai, K; Iyobe, S; Jakics, EB | 1 |
Fallara, A; Ravaoarinoro, M; Toma, E | 1 |
Fukuda, H; Hirai, K; Hosaka, M; Iyobe, S | 1 |
Rahal, K | 1 |
Renneberg, J; Walder, M | 1 |
Björnegård, B; Brorson, JE; Trollfors, B; Zackrisson, G | 1 |
Klastersky, J; Van der Auwera, P | 1 |
Weinstein, MP | 1 |
Bailer, R; Chu, DT; Fernandes, PB; Hanson, CW; Stamm, JM; Vojtko, C | 1 |
Ogle, JW; Reller, LB; Vasil, ML | 1 |
Gulden, H; Kern, W; Kurrle, E; Vanek, E | 1 |
Berlioux, J; Daguet, GL; Mugnier, P; Pasteau, C; Ygout, JF | 1 |
Bebear, C; Lafferriere, C; Noury, P; Quentin, C; Saivin, S | 1 |
Durgham, SM; Ishag, AJ; Shibl, AM | 1 |
Neu, HC | 1 |
Bebear, C; Laurent, C; Noury, P; Quentin, C; Saivin, S | 1 |
Brandimarte, C; Martino, P; Serra, P; Valente, B; Venditti, M | 1 |
Gadebusch, HH; Shungu, DL; Weinberg, E | 1 |
Ayers, LW; Barnishan, J; Fass, RJ | 1 |
Miller, LA; Poupard, JA; Rittenhouse, SF; Utrup, LJ | 1 |
Kinoshita, S; Kumagai, S | 1 |
Chevalier, J; Eyraud, A; Malléa, M; Pagès, JM | 1 |
Chaves, J; del Carmen Conejo, M; Hernández, G; Joyanes, P; Martínez-Martínez, L; Pascual A, A; Perea, EJ | 1 |
Calvo, A; García, R; Gómez-Lus, ML; Leturia, A; Sevillano, D; Valero, E | 1 |
Fukuda, H; Kawamura, Y | 1 |
Chumjan, W; Hajjar, E; Mahendran, KR; Schulte, A; Suginta, W; Weingart, H; Winterhalter, M | 1 |
Fallah, F; Goudarzi, M; Jahromi, MH; Karimi, A; Navidinia, M; Sajadi Nia, RS; Shiva, F | 1 |
Matar, GM; Nassar, FJ; Rahal, EA; Sabra, A | 1 |
Gonçalves de Souza, T; Karine de Sousa, A; Melo Coutinho, HD; Ribeiro-Filho, J; Rocha, JE; Sampaio de Freitas, T | 1 |
Akrami, S; Alkhudhairy, MK; Benyagoub, E; Raouf, FEA; Saki, M | 1 |
Abulreesh, HH; Ahmad, I; Aldosari, MS; Alshehri, WA; Arafa, SH; Asiri, FH; Elbanna, K; Obaid, NA; Organji, SR | 1 |
3 review(s) available for norfloxacin and imipenem, anhydrous
Article | Year |
---|---|
Current scenario of tetrazole hybrids for antibacterial activity.
Topics: Anti-Bacterial Agents; Bacteria; Dose-Response Relationship, Drug; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship; Tetrazoles | 2019 |
Cephalosporins, vancomycin, aminoglycosides and other drugs, especially in combination, for the treatment of methicillin-resistant staphylococcal infections.
Topics: Aminoglycosides; Anti-Bacterial Agents; Cephalosporins; Drug Therapy, Combination; Glycopeptides; Imipenem; Methicillin; Norfloxacin; Oxacillin; Pefloxacin; Penicillin Resistance; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Staphylococcus epidermidis; Teicoplanin; Thienamycins; Vancomycin | 1986 |
New antibiotics: areas of appropriate use.
Topics: Anti-Bacterial Agents; Aztreonam; Bacterial Infections; beta-Lactamase Inhibitors; Cephalosporins; Ciprofloxacin; Enoxacin; Humans; Imipenem; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Thienamycins | 1987 |
46 other study(ies) available for norfloxacin and imipenem, anhydrous
Article | Year |
---|---|
Development and persistence of antimicrobial resistance in Pseudomonas aeruginosa: a longitudinal observation in mechanically ventilated patients.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Drug Resistance, Bacterial; Humans; Longitudinal Studies; Pneumonia, Ventilator-Associated; Polymerase Chain Reaction; Pseudomonas aeruginosa; Pseudomonas Infections | 2007 |
Spread of extended-spectrum beta-lactamase CTX-M-producing escherichia coli clinical isolates in community and nosocomial environments in Portugal.
Topics: Aged; Anti-Bacterial Agents; beta-Lactamases; Community-Acquired Infections; Cross Infection; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Humans; Microbial Sensitivity Tests; Middle Aged; Portugal | 2007 |
Cloning, nucleotide sequencing, and analysis of the AcrAB-TolC efflux pump of Enterobacter cloacae and determination of its involvement in antibiotic resistance in a clinical isolate.
Topics: Bacterial Proteins; Base Sequence; beta-Lactamases; Carrier Proteins; Cloning, Molecular; DNA, Bacterial; Drug Resistance, Bacterial; Enterobacter cloacae; Enterobacteriaceae Infections; Genes, MDR; Genetic Vectors; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; Porins | 2007 |
Role of lon, an ATP-dependent protease homolog, in resistance of Pseudomonas aeruginosa to ciprofloxacin.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Ciprofloxacin; Drug Resistance, Bacterial; Fluoroquinolones; Gene Expression Regulation, Bacterial; Heat-Shock Proteins; Microbial Sensitivity Tests; Oligonucleotide Array Sequence Analysis; Protease La; Pseudomonas aeruginosa | 2007 |
Plasmid-mediated qepA gene among Escherichia coli clinical isolates from Japan.
Topics: Anti-Bacterial Agents; Conjugation, Genetic; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Fluoroquinolones; Hospitals; Humans; Japan; Microbial Sensitivity Tests; Plasmids; Prevalence | 2008 |
Spread of OXA-48-positive carbapenem-resistant Klebsiella pneumoniae isolates in Istanbul, Turkey.
Topics: Bacterial Proteins; beta-Lactamases; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Models, Genetic; Turkey | 2008 |
Plasmid-mediated quinolone resistance pump QepA2 in an Escherichia coli isolate from France.
Topics: Aged; Base Sequence; DNA Primers; DNA, Bacterial; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Female; Fluoroquinolones; France; Genes, Bacterial; Humans; Models, Genetic; Molecular Sequence Data; Plasmids | 2008 |
Plasmid-mediated 16S rRNA methylases among extended-spectrum beta-lactamase-producing Enterobacteriaceae isolates.
Topics: Anti-Bacterial Agents; beta-Lactamases; Conjugation, Genetic; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Escherichia coli; Humans; Methyltransferases; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; Sequence Analysis, DNA; Transformation, Bacterial | 2008 |
Detection of the pandemic O25-ST131 human virulent Escherichia coli CTX-M-15-producing clone harboring the qnrB2 and aac(6')-Ib-cr genes in a dog.
Topics: Animals; Anti-Bacterial Agents; Dogs; Drug Resistance, Bacterial; Escherichia coli; Genes, Bacterial; Humans; Plasmids; Virulence | 2009 |
Occurrence of efflux mechanism and cephalosporinase variant in a population of Enterobacter aerogenes and Klebsiella pneumoniae isolates producing extended-spectrum beta-lactamases.
Topics: Bacterial Proteins; beta-Lactamases; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Cefepime; Cephalosporinase; Cephalosporins; Drug Resistance, Bacterial; Enterobacter aerogenes; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests | 2009 |
First detection of plasmid-encoded blaOXY beta-lactamase.
Topics: beta-Lactamases; Blotting, Southern; Child, Preschool; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Humans; Klebsiella; Klebsiella oxytoca; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Plasmids; Polymerase Chain Reaction | 2009 |
CraA, a major facilitator superfamily efflux pump associated with chloramphenicol resistance in Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Aminoglycosides; Anti-Bacterial Agents; Bacterial Proteins; Chloramphenicol Resistance; Drug Resistance, Multiple, Bacterial; Imipenem; Microbial Sensitivity Tests; Polymerase Chain Reaction; Quinolones; Tetracyclines | 2009 |
Role of AbeS, a novel efflux pump of the SMR family of transporters, in resistance to antimicrobial agents in Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Amino Acid Sequence; Anti-Bacterial Agents; Bacterial Proteins; Drug Resistance, Multiple, Bacterial; Escherichia coli; Membrane Transport Proteins; Microbial Sensitivity Tests; Molecular Sequence Data; Sequence Homology, Amino Acid | 2009 |
Screening and quantification of the expression of antibiotic resistance genes in Acinetobacter baumannii with a microarray.
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; DNA, Bacterial; DNA, Complementary; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Genes, MDR; Metals, Heavy; Microbial Sensitivity Tests; Mutation; Oligonucleotide Array Sequence Analysis; Reproducibility of Results; Reverse Transcriptase Polymerase Chain Reaction; RNA, Bacterial | 2010 |
Antimicrobial susceptibilities of multidrug-resistant Campylobacter jejuni and C. coli strains: in vitro activities of 20 antimicrobial agents.
Topics: Anti-Bacterial Agents; Campylobacter coli; Campylobacter Infections; Campylobacter jejuni; Carbapenems; Drug Resistance, Multiple, Bacterial; Erythromycin; Feces; Finland; Humans; Macrolides; Microbial Sensitivity Tests; Minocycline; Tigecycline | 2010 |
Computational analysis of structure-based interactions and ligand properties can predict efflux effects on antibiotics.
Topics: Anti-Bacterial Agents; beta-Lactams; Computational Biology; Drug Resistance, Bacterial; Hydrophobic and Hydrophilic Interactions; Ligands; Membrane Transport Proteins; Microbial Sensitivity Tests; Models, Molecular; Protein Binding; Protein Conformation; Quantitative Structure-Activity Relationship; Regression Analysis; Thermodynamics | 2012 |
Emergence of quinolone-imipenem cross-resistance in Pseudomonas aeruginosa after fluoroquinolone therapy.
Topics: Anti-Infective Agents; Drug Resistance, Microbial; Drug Therapy, Combination; Fluoroquinolones; Humans; Imipenem; Microbial Sensitivity Tests; Mutation; Naphthyridines; Norfloxacin; Pseudomonas aeruginosa; Pseudomonas Infections; Quinolones | 1992 |
Occurrence of the nfxB type mutation in clinical isolates of Pseudomonas aeruginosa.
Topics: Carbenicillin; Chloramphenicol; Drug Resistance, Microbial; Genes, Bacterial; Gentamicins; Imipenem; Microbial Sensitivity Tests; Mutation; Norfloxacin; Phenotype; Plasmids; Pseudomonas aeruginosa; Transformation, Bacterial | 1992 |
Inducible beta-lactamases in clinical isolates of non-aeruginosa Pseudomonas.
Topics: beta-Lactamases; Cefazolin; Chloromercuribenzoates; Ciprofloxacin; Clavulanic Acids; Cloxacillin; Dose-Response Relationship, Drug; Drug Resistance, Microbial; Edetic Acid; Humans; Hydrolysis; Imipenem; Isoelectric Point; Molecular Weight; Norfloxacin; Prospective Studies; Pseudomonas aeruginosa; Pseudomonas Infections; Spectrophotometry | 1992 |
New norfloxacin resistance gene in Pseudomonas aeruginosa PAO.
Topics: Bacterial Outer Membrane Proteins; Cell Membrane; Chromosome Mapping; Drug Resistance, Microbial; Imipenem; Microbial Sensitivity Tests; Mutation; Norfloxacin; Permeability; Pseudomonas aeruginosa | 1990 |
[Activity of cefotaxime and ceftriaxone and of imipenem, pefloxacin and norfloxacin on 13 species of bacteria].
Topics: Bacteria; Cefotaxime; Ceftriaxone; Drug Resistance, Microbial; Imipenem; Microbial Sensitivity Tests; Norfloxacin; Pefloxacin; Species Specificity | 1989 |
Postantibiotic effects of imipenem, norfloxacin, and amikacin in vitro and in vivo.
Topics: Amikacin; Animals; Bacteria; Bacterial Infections; Enterococcus faecalis; Escherichia coli; Female; Imipenem; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Norfloxacin; Protein Binding; Pseudomonas aeruginosa; Staphylococcus aureus | 1989 |
Susceptibility of Bordetella pertussis to doxycycline, cinoxacin, nalidixic acid, norfloxacin, imipenem, mecillinam and rifampicin.
Topics: Amdinocillin; Anti-Bacterial Agents; Bordetella pertussis; Cinoxacin; Doxycycline; Imipenem; Microbial Sensitivity Tests; Nalidixic Acid; Norfloxacin; Rifampin; Thienamycins | 1985 |
Comparative in vitro activity of lomefloxacin and other antimicrobials against 597 microorganisms causing bacteremia.
Topics: Anti-Bacterial Agents; Bacteria; Cefotaxime; Ceftazidime; Enoxacin; Fluoroquinolones; Humans; Imipenem; Microbial Sensitivity Tests; Norfloxacin; Quinolones; Sepsis; Tobramycin | 1988 |
In vitro evaluation of A-56619 (difloxacin) and A-56620: new aryl-fluoroquinolones.
Topics: Anti-Infective Agents; Aztreonam; Bacteria; Cefotaxime; Ciprofloxacin; Drug Combinations; Enterobacteriaceae; Escherichia coli; Fluoroquinolones; Gentamicins; Haemophilus influenzae; Half-Life; Humans; Imipenem; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Norfloxacin; Penicillins; Piperacillin; Piperazines; Pseudomonas aeruginosa; Quinolines; Staphylococcus aureus; Streptococcus; Thienamycins | 1986 |
Development of resistance in Pseudomonas aeruginosa to imipenem, norfloxacin, and ciprofloxacin during therapy: proof provided by typing with a DNA probe.
Topics: Ciprofloxacin; DNA, Bacterial; Drug Resistance, Microbial; Imipenem; Norfloxacin; Plasmids; Pseudomonas aeruginosa; Thienamycins | 1988 |
In vitro antibacterial activity of imipenem in combination with newer quinolone derivatives.
Topics: Amikacin; Anti-Bacterial Agents; Bacteria; Ciprofloxacin; Drug Evaluation, Preclinical; Drug Interactions; Drug Resistance, Microbial; Humans; Imipenem; Norfloxacin; Ofloxacin; Oxazines; Thienamycins | 1988 |
[Phenotypes of resistance to antibiotics of Acinetobacter baumannii. Impact on therapeutic orientation].
Topics: Acinetobacter; Acinetobacter Infections; Amikacin; Anti-Bacterial Agents; Drug Resistance, Microbial; Gentamicins; Humans; Imipenem; Norfloxacin; Pefloxacin; Phenotype; Thienamycins | 1988 |
In vitro activity of fosfomycin combined with rifampin, pefloxacin and imipenem against staphylococci: a study by the time-kill curve method.
Topics: Anti-Bacterial Agents; Drug Antagonism; Drug Interactions; Drug Synergism; Fosfomycin; Imipenem; Microbial Sensitivity Tests; Norfloxacin; Pefloxacin; Rifampin; Staphylococcus; Staphylococcus aureus; Staphylococcus epidermidis; Thienamycins | 1987 |
In vitro susceptibility of methicillin-resistant Staphylococcus aureus to imipenem and other antimicrobial agents.
Topics: Amikacin; Anti-Bacterial Agents; Cefepime; Cephalosporins; Clindamycin; Fusidic Acid; Imipenem; Methicillin; Microbial Sensitivity Tests; Norfloxacin; Pefloxacin; Penicillin Resistance; Rifampin; Staphylococcus aureus; Thienamycins; Tobramycin; Vancomycin | 1987 |
[In vitro action of fosfomycin combined with rifampicin, pefloxacin and imipenem on staphylococci (checkerboard method in a liquid medium)].
Topics: Anti-Bacterial Agents; Drug Synergism; Fosfomycin; Humans; Imipenem; Norfloxacin; Pefloxacin; Rifampin; Staphylococcus; Thienamycins | 1987 |
N-formimidoyl-thienamycin and norfloxacin against multiple-resistant Pseudomonas aeruginosa strains. Combined in vitro activity and comparison with 14 other antibiotics.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Aztreonam; Drug Resistance, Microbial; Imipenem; Microbial Sensitivity Tests; Norfloxacin; Pseudomonas aeruginosa; Thienamycins | 1985 |
Effectiveness of the antimicrobial removal device, BACTEC 16B medium, and thiol broth in neutralizing antibacterial activities of imipenem, norfloxacin, and related agents.
Topics: Anti-Bacterial Agents; Bacteria; Bacteriological Techniques; Blood; Cefoxitin; Ceftazidime; Cephalosporins; Culture Media; Evaluation Studies as Topic; Humans; Imipenem; Moxalactam; Nalidixic Acid; Norfloxacin; Oxolinic Acid; Sulfhydryl Compounds; Thienamycins; Urine | 1984 |
Emergence of bacterial resistance to imipenem and ciprofloxacin in a university hospital.
Topics: Anti-Infective Agents; Bacteria; Ciprofloxacin; Cross Infection; Drug Resistance, Microbial; Drug Utilization; Humans; Imipenem; Microbial Sensitivity Tests; Norfloxacin; Oxacillin; Penicillins; Thienamycins | 1995 |
Evaluation of 500 gram negative isolates to determine the number of major susceptibility interpretation discrepancies between the Vitek and MicroScan Walkaway for 9 antimicrobial agents.
Topics: Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Clavulanic Acid; Clavulanic Acids; Enterobacter; Escherichia coli; Imipenem; Klebsiella pneumoniae; Mezlocillin; Microbial Sensitivity Tests; Norfloxacin; Penicillins; Piperacillin; Proteus mirabilis; Pseudomonas aeruginosa; Quality Control; Reproducibility of Results; Sulbactam; Thienamycins; Ticarcillin | 1996 |
[Antimicrobial activity of carbapenem antibiotics against gram-negative bacilli].
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Aztreonam; Carbapenems; Cefozopran; Ceftazidime; Cephalosporins; Drug Resistance, Microbial; Enterobacteriaceae; Gram-Negative Bacteria; Humans; Imipenem; Meropenem; Monobactams; Norfloxacin; Tetracycline; Thienamycins | 1998 |
Membrane permeability modifications are involved in antibiotic resistance in Klebsiella pneumoniae.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Outer Membrane Proteins; beta-Lactamases; Cell Membrane Permeability; Drug Resistance, Microbial; Imipenem; Klebsiella pneumoniae; Microbial Sensitivity Tests; Norfloxacin | 2000 |
[The activity of four fluoroquinolones against strains of Pseudomonas aeruginosa with a different sensitivity pattern to ceftazidime and imipenem].
Topics: 4-Quinolones; Anti-Infective Agents; Ceftazidime; Ciprofloxacin; Drug Resistance; Fluoroquinolones; Humans; Imipenem; Microbial Sensitivity Tests; Norfloxacin; Pefloxacin; Pseudomonas aeruginosa; Pseudomonas Infections; Spain | 2001 |
[Activity of new fluoroquinolones against clinical isolates of Acinetobacter baumannii].
Topics: Acinetobacter; Acinetobacter Infections; Ampicillin; Anti-Infective Agents; Aza Compounds; Cefepime; Cephalosporins; Ciprofloxacin; Colistin; Fluoroquinolones; Gatifloxacin; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Moxifloxacin; Nalidixic Acid; Naphthyridines; Norfloxacin; Ofloxacin; Opportunistic Infections; Quinolines; Sulbactam; Thienamycins | 2001 |
[Drug interactions between nonsteroidal anti-inflammatory drug and pazufloxacin mesilate, a new quinolone antibacterial agent for intravenous use: convulsions in mice after intravenous or intracerebroventricular administration].
Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Inflammatory Agents, Non-Steroidal; beta-Alanine; Biphenyl Compounds; Cefazolin; Cilastatin; Cilastatin, Imipenem Drug Combination; Ciprofloxacin; Convulsants; Drug Combinations; Drug Interactions; Enoxacin; Fleroxacin; Fluoroquinolones; Imipenem; Injections, Intravenous; Injections, Intraventricular; Male; Mice; Mice, Inbred ICR; Norfloxacin; Oxazines; Penicillin G; Quinolones; Seizures; Thienamycins | 2002 |
Molecular analysis of antimicrobial agent translocation through the membrane porin BpsOmp38 from an ultraresistant Burkholderia pseudomallei strain.
Topics: Amino Acid Sequence; Anti-Infective Agents; Bacterial Outer Membrane Proteins; beta-Lactams; Biological Transport; Burkholderia pseudomallei; Cefepime; Ceftazidime; Cephalosporins; Ertapenem; Humans; Imipenem; Kinetics; Lipid Bilayers; Melioidosis; Meropenem; Models, Molecular; Molecular Sequence Data; Norfloxacin; Penicillin G; Phospholipids; Porins; Protein Conformation; Sequence Homology, Amino Acid; Thienamycins | 2011 |
Determination of integron frequency by a polymerase chain reaction-restriction fragment length polymorphism method in multidrug-resistant Escherichia coli, which causes urinary tract infections.
Topics: Adult; Anti-Bacterial Agents; Drug Resistance, Multiple, Bacterial; Escherichia coli Infections; Female; Humans; Imipenem; Integrons; Male; Microbial Sensitivity Tests; Norfloxacin; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Urinary Tract Infections; Uropathogenic Escherichia coli | 2012 |
Effects of subinhibitory concentrations of antimicrobial agents on Escherichia coli O157:H7 Shiga toxin release and role of the SOS response.
Topics: Anti-Infective Agents; Azithromycin; DNA, Bacterial; Escherichia coli O157; Gene Expression Regulation, Bacterial; Genes, Bacterial; Gentamicins; Humans; Imipenem; Latex Fixation Tests; Microbial Sensitivity Tests; Norfloxacin; Prophages; Real-Time Polymerase Chain Reaction; Rifampin; Shiga Toxin; SOS Response, Genetics | 2013 |
New roles of fluoxetine in pharmacology: Antibacterial effect and modulation of antibiotic activity.
Topics: Anti-Bacterial Agents; Antidepressive Agents; Bacteria; Drug Combinations; Drug Synergism; Erythromycin; Escherichia coli; Fluoxetine; Gentamicins; Imipenem; Microbial Sensitivity Tests; Norfloxacin; Pseudomonas aeruginosa; Staphylococcus aureus; Tetracycline | 2018 |
Extended-spectrum beta-lactamases among Klebsiella pneumoniae from Iraqi patients with community-acquired pneumonia.
Topics: Anti-Bacterial Agents; beta-Lactamases; Humans; Imipenem; Iraq; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Norfloxacin; Pneumonia | 2022 |
Antimicrobial Resistance, Virulence Factor-Encoding Genes, and Biofilm-Forming Ability of Community-Associated Uropathogenic
Topics: Agar; Ampicillin; Animals; Anti-Bacterial Agents; Biofilms; Drug Resistance, Bacterial; Ertapenem; Escherichia coli Infections; Female; Imipenem; Meropenem; Norfloxacin; Saudi Arabia; Sheep; Urinary Tract Infections; Uropathogenic Escherichia coli; Virulence Factors | 2022 |